Calumet, Inc.

CLMT Basic Materials Specialty Chemicals

Calumet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.1 billion, down 1.25% from fiscal 2024. In the quarter to June 2026, revenue grew 40.8%, EPS grew 35.9%, free cash flow grew 450.7% and total debt fell 1.98%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

57.75 0.49 −0.84%
Market cap
$5.1B
P/E
0.0×
Fwd P/E
−9.0×
Dividend yield
—
F-score
5/9
Altman Z
1.16
Beneish M
−2.96
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Revenue

+8 more quarters

1,078.00 1,038.60 1,029.70 1,445.10
Revenue Growth
(2.04%) 9.38% 3.60% 40.77%
Gross Profit
373.70 (3.00) (87.50) 18.30
Operating Income
322.90 (64.50) (171.30) (40.00)
EBT
272.00 (89.10) (337.80) (117.10)
Income after Tax
313.40 (37.30) (317.00) (95.90)
Net Income Common
313.40 (37.30) (317.00) (95.90)
EPS (Diluted)
3.61 (0.43) (3.64) (1.09)
Shares (Diluted, Weighted)
86.90 86.76 87.00 87.59
Gross Margin
34.67% (0.29%) (8.50%) 1.27%
EBIT Margin
29.95% (6.21%) (16.64%) (2.77%)
Net Profit Margin
29.07% (3.59%) (30.79%) (6.64%)
EBITDA
322.90 (64.50) (129.80) 5.30
EBIT
322.90 (64.50) (171.30) (40.00)

Show all line items

In millions of $ except per-share values · columns are period end dates